|
The M.D. Anderson Cancer Center is
recruiting smokers to test Celebrex, a similar drug that has
linked to heart attacks
"Researchers
say patients who agree to take Pfizer Inc.'s Celebrex to gauge
whether it prevents lung damage will be monitored for
cardiovascular changes and aggressively treated if
necessary," according to an AP
article filed by Yahoo.com. Because
of the heart attacks some attribute to VIOXX, the studies on
Celebrex were suspended. Before the suspension; however,
Celebrex showed signs of blocking enzymes that contribute to
lung cancer.
Soon we will have an interactive
forum covering all aspects today's drug issues. Until then you
can e-mail us your comments and we will post them to the forum
as soon as it is active. E-mail
Us!
|
| Last
year, the drug industry spent $4.02 billion on ads, up 23
percent from 2003 and 62 percent from 2000, according to
consulting firm IMS Health.
CNN |
|
|
